Blackstone Inc
AEON icon

Blackstone Inc’s AEON Biopharma AEON Stock Holding History

Blackstone Inc’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-558
Closed -$403K – 166
2022
Q4 		$403K Hold
558
– – ﹤0.01% 138
2022
Q3 		$395K Hold
558
– – ﹤0.01% 169
2022
Q2 		$393K Hold
558
– – ﹤0.01% 190
2022
Q1 		$393K Sell
558
-6,386
-92% -$4.48M ﹤0.01% 204
2021
Q4 		$4.86M Hold
6,944
– – 0.01% 219
2021
Q3 		$4.87M Hold
6,944
– – 0.01% 252
2021
Q2 		$4.82M Buy
+6,944
New +$4.85M 0.01% 256

Other funds holding AEON

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
GCWM
Graham Capital Wealth Management Washington D.c., District of Columbia $113M AUM 11.26% 1-Year Est. Return

Blackstone Inc's AEON Position: Q1 2023 in Review

Blackstone Inc sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 558 shares — an estimated $403K sold.

Blackstone Inc first reported a position in AEON in Q2 2021 and held it in 7 quarters. The position peaked at $4.87M in Q3 2021. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

  • Blackstone Inc reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
  • Blackstone Inc sold 558 AEON Biopharma shares in Q1 2023, an estimated $403K.
  • Blackstone Inc first reported a position in AEON Biopharma in Q2 2021 and held it in 7 quarters.
  • Blackstone Inc's AEON Biopharma position peaked at $4.87M in Q3 2021.
  • 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Blackstone Inc's 13F filing for Q1 2023, filed 15 May 2023.